Use of Etonogestrel-releasing Contraceptive Implant in Women With Sickle Cell Disease
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 25 May 2016
At a glance
- Drugs Etonogestrel (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- 10 May 2016 Planned End Date changed from 1 Nov 2016 to 1 Nov 2018.
- 10 May 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jan 2018.
- 10 May 2016 Status changed from recruiting to active, no longer recruiting.